Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Murine melanoma cells incomplete reprogramming using non‐viral vector

View through CrossRef
AbstractObjectivesThe reprogramming of cancer cells into induced pluripotent stem cells or less aggressive cancer cells can provide a modern platform to study cancer‐related genes and their interactions with cell environment before and after reprogramming. Herein, we aimed to investigate the reprogramming capacity of murine melanoma B16F10 cells.Materials and methodsThe B16F10 was transfected using non‐viral circular DNA plasmid containing the genes Sox‐2, Oct4, Nanog, Lin28 and green fluorescent protein (GFP). These cells were characterized by immunofluorescence, analysis RT‐PCR and cell cycle.ResultsOur results demonstrated for the first time that reprogramming of B16F10 may be induced using non‐viral minicircle DNA containing the four reprogramming factors Oct4, Sox2, Lin 28, Nanog (OSLN) and the GFP reporter gene. The resulting clones are composed by epithelioid cells. These cells display characteristics of cancer stem cells, thus expressing pluripotent stem cell markers and dividing asymmetrically and symmetrically. Reprogrammed B16F10 cells did not form teratomas; however, they showed the suppression of tumourigenic abilities characterized by a reduced tumour size, when compared with parental B16F10 cell line. In contrast to parental cell line that showed accumulation of the cells in S phase of cell cycle, the cells of reprogrammed clones are accumulated in G1 phase. Long‐term cultivation of reprogrammed B16F10 cells induces regression of their reprogramming.ConclusionsOur data imply that in result of reprogramming of B16F10 cells less aggressive Murine Melanoma Reprogrammed Cancer Cells may be obtained. These cells represent an interesting model to study mechanism of cells malignancy as well as provide a novel tool for anti‐cancer drugs screening.
Title: Murine melanoma cells incomplete reprogramming using non‐viral vector
Description:
AbstractObjectivesThe reprogramming of cancer cells into induced pluripotent stem cells or less aggressive cancer cells can provide a modern platform to study cancer‐related genes and their interactions with cell environment before and after reprogramming.
Herein, we aimed to investigate the reprogramming capacity of murine melanoma B16F10 cells.
Materials and methodsThe B16F10 was transfected using non‐viral circular DNA plasmid containing the genes Sox‐2, Oct4, Nanog, Lin28 and green fluorescent protein (GFP).
These cells were characterized by immunofluorescence, analysis RT‐PCR and cell cycle.
ResultsOur results demonstrated for the first time that reprogramming of B16F10 may be induced using non‐viral minicircle DNA containing the four reprogramming factors Oct4, Sox2, Lin 28, Nanog (OSLN) and the GFP reporter gene.
The resulting clones are composed by epithelioid cells.
These cells display characteristics of cancer stem cells, thus expressing pluripotent stem cell markers and dividing asymmetrically and symmetrically.
Reprogrammed B16F10 cells did not form teratomas; however, they showed the suppression of tumourigenic abilities characterized by a reduced tumour size, when compared with parental B16F10 cell line.
In contrast to parental cell line that showed accumulation of the cells in S phase of cell cycle, the cells of reprogrammed clones are accumulated in G1 phase.
Long‐term cultivation of reprogrammed B16F10 cells induces regression of their reprogramming.
ConclusionsOur data imply that in result of reprogramming of B16F10 cells less aggressive Murine Melanoma Reprogrammed Cancer Cells may be obtained.
These cells represent an interesting model to study mechanism of cells malignancy as well as provide a novel tool for anti‐cancer drugs screening.

Related Results

Abstract LB163: Germline pathogenic variants in melanoma patients
Abstract LB163: Germline pathogenic variants in melanoma patients
Abstract Background: The etiology of melanoma has generally been thought to be exposure to UV radiation (sun and sun tanning lamps). However, the percent of melanoma...
Successful transfection of Lymphoblastoid cell line (Preprint)
Successful transfection of Lymphoblastoid cell line (Preprint)
BACKGROUND Immortalization is the stage that the cell goes through before full transformation [1]. Human resting B lymphocytes from peripheral blood are eas...
Pyridinium derivatives for metastatic melanoma therapy
Pyridinium derivatives for metastatic melanoma therapy
<p>Melanoma incidence is increasing faster than any other cancer worldwide.1 Early detection is often curative, but metastatic melanoma is lethal (5-year survival <20%) du...
Modeling melanoma in reconstructed human skin
Modeling melanoma in reconstructed human skin
With increasing pressure from the European Union to replace, reduce, and refine animal experiments, there is a critical need for models that reliably mimic human diseases in a phys...
Abstract 1631: Cav1 is a key mediator of tumor-stromal interactions in melanoma.
Abstract 1631: Cav1 is a key mediator of tumor-stromal interactions in melanoma.
Abstract Several lines of experimental evidence have demonstrated the importance of the tumor microenvironment in controlling melanoma tumor growth and melanoma meta...
Precursors of skin melanoma (melanoma-sensitive nevi)
Precursors of skin melanoma (melanoma-sensitive nevi)
Interest in melanoma precursors, or melanoma-sensitive skin nevi, has not lost its relevance for many years due to the steady increase of skin melanoma morbidity in recent decades ...
Abstract 1297: The heritability of melanoma differs between light- and dark-skinned individuals of European descent
Abstract 1297: The heritability of melanoma differs between light- and dark-skinned individuals of European descent
Abstract Melanoma is strongly associated with exposure to ultraviolet radiation (UV). The prevalence of melanoma is much higher in lighter-skinned Caucasians as comp...
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
<p>Supplementary Methods, Supplementary Figures S1-S15 Fig. S1. Purification and binding specificity of MV-encoded BiTEs. (A) Purification of MV-expressed BiTEs. Vero cells w...

Back to Top